02176nas a2200409 4500000000100000008004100001260001700042653001500059653001000074653000900084653001800093653001000111653002200121653003700143653001100180653002200191653002000213653001100233653001000244653001200254653000900266653001600275653001700291653002400308653001600332100001300348700001300361700001400374700001600388245006100404856007800465300001000543490000700553050003200560520116000592022001401752 2009 d c2009 Jul-Sep10aAdolescent10aAdult10aAged10aBlood Glucose10aChild10aDiabetes Mellitus10aDose-Response Relationship, Drug10aFemale10aFollow-Up Studies10aGlucocorticoids10aHumans10aIndia10aleprosy10aMale10aMiddle Aged10aPrednisolone10aProspective Studies10aYoung Adult1 aPapang R1 aJohn A S1 aAbraham S1 aRao P S S S00aA study of steroid-induced diabetes mellitus in leprosy. uhttp://www.ijl.org.in/July-Sept%202009_PDF%20Files/3_Abst%20(125-130).pdf a125-90 v81 aInfolep Library - available3 a

Steroids, while still the most powerful drugs to manage leprosy reactions, predispose some patients to other morbidities such as diabetes, glaucoma, hypertension etc. A prospective cohort study was done in Kolkata, India among leprosy patients in reaction to determine the extent of steroid induced diabetes mellitus (SID). All leprosy patients with type 1 or type 2 reactions or neuritis admitted in 2006 to the Leprosy Mission Hospital in Kolkata, who had no past or current history and whose blood sugars on fasting were <126 mg/dl or postprandial <200 mg/dl were monitored fortnightly while on steroid therapy, estimating blood glucose by a glucometer using standard strips. Of 81 patients, 19 (23.5%) manifested steroid-induced diabetes mellitus. Compared to those who didn't, there were significantly more LL/BL patients with positive BI among SID whose cumulative prednisolone dosage was nearly 9000 mg as compared to half the amount among others. Steroid induced diabetes is a serious complication among leprosy patients treated with prednisolone for reactions requiring careful monitoring for detection and appropriate clinical management.

 a0254-9395